People who are experiencing anxiety and depression months after a mild case of COVID-19 may have changes affecting the structure and function of their brains, Brazilian researchers report.
American adults who have epilepsy and are Black or Hispanic are less likely than white adults to be prescribed the latest medications, according to new research.